Parkinson's Diseases Susceptibility Genes and Pesticides
NCT00044590 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1870
Last updated 2017-05-16
Summary
Parkinson's disease (PD) occurrence is higher in rural than in urban populations of industrialized countries. Epidemiologic and human tissue studies suggest that pesticides may be responsible for causing dopaminergic cell death at increased rates. While many pathophysiologic pathways may be involved in the neurodegeneration responsible for PD, genetic factors are likely to determine a general susceptibility to neurodegeneration.
Conditions
Sponsors & Collaborators
-
University of California, Los Angeles
collaborator OTHER -
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Principal Investigators
-
Beate Ritz, MD, PhD · UCLA Department of Epidemiology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-09-01
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- United States
Study Locations
More Related Trials
-
Mutations Associated With Parkinson s Disease
NCT01547832 ·Status: TERMINATED
-
Parkinson's Genes and Environment Study
NCT00367900 ·Status: COMPLETED
-
Attention and Eye Movement in Parkinson's Disease
NCT06899022 ·Status: RECRUITING ·Phase: NA
-
Hereditary Parkinson s Disease Natural History Protocol
NCT02511015 ·Status: COMPLETED
-
Catechol Thioethers in Parkinson's Disease
NCT00042692 ·Status: COMPLETED
-
Oxidative Stress in Motor Neuron Disease: COSMOS Add-On Study
NCT01143428 ·Status: COMPLETED
-
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
NCT06301282 ·Status: RECRUITING
-
Environmental Epidemiology of Essential Tremor
NCT04576676 ·Status: COMPLETED
-
Physiological Effects of Nutritional Support in Patients With Parkinson's Disease
NCT02445651 ·Status: COMPLETED ·Phase: NA
-
Functional Characterization of Parkin + Patients
NCT00142311 ·Status: TERMINATED
-
Relationship of Dopamine to Cognitive Function in Parkinson's Disease
NCT00094601 ·Status: COMPLETED
-
Evaluation of a Biomarker Related to the GI Tract for the Diagnosis of Parkinson's Disease
NCT01904240 ·Status: COMPLETED
-
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
NCT01429207 ·Status: COMPLETED
-
PET Study of Non-Motor Symptoms of Parkinson Disease
NCT01565473 ·Status: COMPLETED
-
Clinical and Physiological Studies of Tremor Syndromes
NCT03027310 ·Status: COMPLETED
-
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") Dysfunction
NCT03421899 ·Status: COMPLETED
-
Assessment of Three-dimensional Vision Alteration in Parkinson Disease
NCT01620164 ·Status: COMPLETED ·Phase: NA
-
Natural History Protocol for Movement Disorders
NCT05413291 ·Status: RECRUITING
-
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
NCT04925622 ·Status: COMPLETED
-
Risk Factors for Progressive Supranuclear Palsy (PSP)
NCT00431301 ·Status: COMPLETED
-
Ketogenic Diets for Symptoms of Parkinson's Disease
NCT01364545 ·Status: UNKNOWN ·Phase: NA
-
Twins and the Risk of Parkinson's Disease: A Clinical and Imaging Study
NCT00282802 ·Status: UNKNOWN
-
Microbiome Composition and Function Contributes to Cognitive Impairment and Neuroinflammation in Parkinson's Disease
NCT05419453 ·Status: RECRUITING
-
Web-based Genetic Research on Parkinson's Disease
NCT01351467 ·Status: COMPLETED
-
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
NCT02458430 ·Status: COMPLETED